Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation.
Saved in:
| Title: | Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation. |
|---|---|
| Authors: | Illamola SM; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States., Bhongsatiern JJ; Department of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, United States.; Quantitative Pharmacology, Regeneron Pharmaceuticals, Tarrytown, NY, United States., Birnbaum AK; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States., Kumar SS; Clinical Pharmacology Modeling Simulation, Parexel International, Sydney, NSW, Australia., Courter JD; Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Haslam DB; Division of Infectious Diseases, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Allegaert K; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands., Reith DM; Office of the Dean, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Desai PB; Department of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, United States., Sherwin CM; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.; Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States.; Internal Medicine, UWA Medical School, The University of Western Australia, Perth, WA, Australia.; Clinical Pharmacology and Pharmacometrics, Differentia Biotech Ltd., San Francisco, CA, United States. |
| Source: | Frontiers in antibiotics [Front Antibiot] 2025 May 08; Vol. 4, pp. 1568931. Date of Electronic Publication: 2025 May 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 9918557185706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-2467 (Electronic) Linking ISSN: 28132467 NLM ISO Abbreviation: Front Antibiot Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2813-2467 |
|---|---|
| DOI: | 10.3389/frabi.2025.1568931 |
